Outcomes of GLP-1 RA in Diabetes & CVD: What are the key opportunities for cardiology practice?
EBAC-accredited E-LearningOnline-CME - This course consists of 3 separate lectures
This CME accredited course consists of 3 separate short (12 - 15 minute) lectures. View and complete all 3 items separately and earn 1 CME credit
In this educational programme the role of GLP-1 ra in the management of patients with diabetes in cardiology practice will be discussed
This course consists of the following 3 lectures
- Diabetes & CVD: Time for a multifactorial approach - Prof. John E. Deanfield, MD, University College London, UK
- GLP-1 receptor agonists: The cardiovascular benefits beyond glucose control - Prof. Filip K. Knop, MD University of Copenhagen, Denmark
- Translating GLP-1 trial outcomes to cardiology practice: Which patients will benefit?- Prof. Lars Rydén, MD Karolinska Institute, Stockholm, Sweden
Educational objectives of this course are to:
- Understand the relation between T2DM & Cardiovascular Disease
- Identify the needs for novel approaches targeting T2DM in cardiovascular prevention
- Explore results from recent cardiovascular outcome trials (CVOT) in T2DM
- Discuss potential mechanisms and multifactorial effects of GLP-1 receptor agonists contributing to cardiovascular benefits
- Review results from recent GLP1 RA outcomes trials, such as LEADER on CV and microvascular outcomes.
- Discuss practical implications from recent CVOTs on treatment and prevention strategies in patients with CV risk and T2DM
- Prof. John E. Deanfield, MD - Professor of Cardiology - Director, National Centre for Cardiovascular Prevention and Outcomes, University College London, United Kingdom-
- Prof. Filip K. Knop, MD - consultant endocrinologist, professor of endocrinology and head of Clinical Metabolic Physiology at Steno Diabetes Center Copenhagen, University of Copenhagen, Denmark
- Prof. Lars Rydén, MD - Senior Professor of Cardiology, Karolinska Institute, Stockholm, Sweden
This educational activity is designed for cardiologists and other healthcare professionals with an interest in treating patients with Diabetes and CVD
This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s).
Supported by an unrestricted educational grant received from Novo Nordisk A/S
This is available as accredited online CME for members. Click the button below to enroll:Enroll